Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BPL

Buckeye Partners

$0.00

(0.00%)

, GSL

Global Ship Lease

$7.60

0.09 (1.20%)

08:30
11/18/19
11/18
08:30
11/18/19
08:30
Options
Twelve option delistings on November 18th »

Option delistings…

BPL

Buckeye Partners

$0.00

(0.00%)

GSL

Global Ship Lease

$7.60

0.09 (1.20%)

HOV

Hovnanian

$23.87

0.14 (0.59%)

HPJ

Highpower International

$0.00

(0.00%)

ONCT

Oncternal Therapeutics

$6.09

0.12 (2.01%)

SLRX

Salarius Pharmaceuticals

$3.65

-0.05 (-1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
SLRX

Salarius Pharmaceuticals

$4.20

-0.05 (-1.18%)

08:29
11/13/19
11/13
08:29
11/13/19
08:29
Hot Stocks
Salarius says seclidemstat trials 'on track' to reach maximum dose in early 2020 »

On September 24, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLRX

Salarius Pharmaceuticals

$4.20

-0.05 (-1.18%)

08:28
11/13/19
11/13
08:28
11/13/19
08:28
Earnings
Salarius Pharmaceuticals reports Q3 EPS (73c) vs. (20c) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLRX

Salarius Pharmaceuticals

$5.00

0.19 (3.95%)

08:25
10/28/19
10/28
08:25
10/28/19
08:25
Hot Stocks
Salarius, Aspire Capital announce a $10.9M stock purchase agreement »

Salarius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
SLRX

Salarius Pharmaceuticals

$5.36

0.18 (3.47%)

08:24
10/08/19
10/08
08:24
10/08/19
08:24
Hot Stocks
Salarius adds MSKCC, Nationwide Children's as sites for Phase 1/2 trial »

Salarius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

SLRX

Salarius Pharmaceuticals

$5.99

(0.00%)

08:10
09/24/19
09/24
08:10
09/24/19
08:10
Hot Stocks
Salarius achieves dose-escalation milestones in Phase 1/2 study of Seclidemstat »

Salarius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

SLRX

Salarius Pharmaceuticals

$6.95

-0.95 (-12.03%)

08:03
09/13/19
09/13
08:03
09/13/19
08:03
Hot Stocks
Salarius appoints Scott Jordan as CBO, Mark Rosenblum as interim CFO »

Salarius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLRX

Salarius Pharmaceuticals

$10.35

1.34 (14.87%)

07:15
08/26/19
08/26
07:15
08/26/19
07:15
Hot Stocks
Salarius, Ivy Brain Tumor Center announce collaborative partnership »

The Ivy Brain Tumor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
SLRX

Salarius Pharmaceuticals

$5.62

-0.38 (-6.33%)

08:17
08/12/19
08/12
08:17
08/12/19
08:17
Hot Stocks
Salarius expects early cohort data readouts for Seclidemstat later in 2020 »

Salarius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLRX

Salarius Pharmaceuticals

$8.90

-1.45 (-14.01%)

15:47
07/30/19
07/30
15:47
07/30/19
15:47
On The Fly
Salarius CEO, in Fly exclusive interview, says trials progressing as expected »

Salarius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.